Literature DB >> 6263403

Susceptibility of Neisseria gonorrhoeae to cefotaxime and ceftizoxime.

E H Sng, V S Rajan, R Pang, K L Yeo.   

Abstract

Two hundred and thirty-nine penicillinase-positive and 240 penicillinase-negative strains of Neisseria gonorrhoeae were tested for their susceptibility to cefotaxime. All were susceptible to cefotaxime at a concentration of 0.062 micrograms/ml. Penicillinase-negative strains were less susceptible than penicillinase-positive strains. This is attributed to the use of prophylactic antibiotics by prostitutes, which has led to the selection of less susceptible penicillinase-negative strains but has not affected the susceptibility of penicillinase-positive strains. The minimum inhibitory concentrations of cefotaxime showed significant positive correlations with those of penicillin, ampicillin, tetracycline, and kanamycin but had a negative correlation with spectinomycin. The related cephalosporin, ceftizoxime, was found to be as effective as cefotaxime against penicillinase-positive and penicillinase-negative gonococci.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263403      PMCID: PMC1045906          DOI: 10.1136/sti.57.3.162

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  7 in total

1.  HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin.

Authors:  R Wise; T Rollason; M Logan; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

2.  In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.

Authors:  C N Baker; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

3.  Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase.

Authors:  H Kojo; M Nishida; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

4.  Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.

Authors:  J P Sosna; P R Murray; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

5.  HR 756--a new cephalosporin in the treatment of gonorrhoea caused by ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.

Authors:  V S Rajan; E H Sng; R Pang; N J Tan; T Thirumoorthy; K L Yeo
Journal:  Br J Vener Dis       Date:  1980-08

6.  Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance.

Authors:  B W Catlin
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

7.  Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.

Authors:  T Kamimura; Y Matsumoto; N Okada; Y Mine; M Nishida; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

  7 in total
  9 in total

1.  Single dose cefoxitin in treating uncomplicated gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.

Authors:  K B Lim; T Thirumoorthy; C T Lee; S N Tham; E H Sng; T Tan
Journal:  Genitourin Med       Date:  1986-08

2.  Three regimens of procaine penicillin G, Augmentin, and probenecid compared for treating acute gonorrhoea in men.

Authors:  K B Lim; T Thirumoorthy; C T Lee; E H Sng; T Tan
Journal:  Genitourin Med       Date:  1986-04

3.  Susceptibility to antimicrobials of Neisseria gonorrhoeae isolated in Singapore: implications on the need for more effective treatment regimens and control strategies.

Authors:  E H Sng; A L Lim; K L Yeo
Journal:  Br J Vener Dis       Date:  1984-12

4.  Two dose Augmentin treatment of acute gonorrhoea in men.

Authors:  K B Lim; V S Rajan; Y C Giam; E O Lui; E H Sng; K L Yeo
Journal:  Br J Vener Dis       Date:  1984-06

5.  Treatment of uncomplicated gonorrhoea with rosoxacin (acrosoxacin).

Authors:  K B Lim; V S Rajan; Y C Giam; E O Lui; E H Sng; K L Yeo
Journal:  Br J Vener Dis       Date:  1984-06

6.  Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected].

Authors:  L L Cheong; R K Chan; M Nadarajah
Journal:  Genitourin Med       Date:  1992-08

Review 7.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

8.  In vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeae.

Authors:  S B Kerbs; J R Stone; S W Berg; W O Harrison
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

Review 9.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.